Scientific Research Activities Sample Clauses

Scientific Research Activities. A considerable scientific research effort by governmental, non-governmental, and academic organizations operating from marine vessels and aircraft occurs annually in the Beaufort Sea and Chukchi Sea. The programs conducted by these organizations are generally expected to have ended for the season, or end for the season during October, but may produce cumulative impacts on resources analyzed for the Noticed Activities. Marine environmental baseline studies involve deployment of oceanographic equipment for collecting water and sediment samples, and use of nets and trawls for fish sampling and collection of phytoplankton, zooplankton, benthic invertebrates, and pelagic invertebrates. Also continuing will be observations of marine and coastal birds and marine mammals using standardized survey transect methods and passive acoustic monitoring. Metocean buoys and acoustic wave and current meters will continue to be deployed for studies of physical oceanography and climate. Previous environmental assessments, such as the environmental assessment for Shell’s Beaufort Sea marine research program, describe the techniques used and the effects of these programs in detail (USDOI, BOEMRE, 2011). 2014 BOEM ANIMIDA III (AK-11-14b). The Arctic Nearshore Impact Monitoring in Development Area (ANIMIDA) and continuation of ANIMIDA (cANIMIDA) started in 1999 and has provided baseline data and monitoring results for chemical contamination, turbidity, Boulder Patch productivity, and subsistence whaling in the vicinity of oil industry development in the Beaufort Sea OCS. Northstar and Liberty prospects were monitored prior to development and Northstar into development and production. Activities include both nearshore and offshore components, both concentrating in the region north and west of Camden Bay. Nearshore components are achieved by small vessel support in the open water season. Larger vessel support will be needed in offshore Camden Bay collections along the Beaufort Sea shelf break. Primary biological/contaminant field surveys should occur in the open-water period, with some effort during breakup with high river flow, and at least once during the ice-covered season. Sediment and biota sampling will be scheduled such that stations sampled in eastern, central, and western Beaufort in ANIMIDA and cANIMIDA will be resampled at least once and the new deeper eastern Beaufort Region stations around Sivulliq and Torpedo would be sampled at least twice. Focus will be on oil and ga...
Sample 1
AutoNDA by SimpleDocs
Scientific Research Activities. SB16_The institution ensures that the research projects contribute to and guarantee a high level of scientific quality in a relevant research area. The institution triggers research, supports academics, and creates an enabling environment for research. An institutional research policy would help the consistency of the research in the benefit of the institutional reputation, allowing the whole academic community and students to reap the benefits of a research-engaged institution. This standard is furthermore a strong relation with the internationalization, as research is intrinsically a cross-border activity. At the same time, students might be invited to participate in project-based activities with companies that will not result in a scientific article. Students might be engaged in entrepreneurship and start a business resulting in a patent. Research should be considered in its broader sense.
Sample 1
Scientific Research Activities. SB.3.1 Research programs (ESG: Not Apply) Guiding questions Does the program have a scientific research plan in line with the faculty/ HEI’s strategic plan? Does the articulation between research and training help to define the institution's strategy? Does the HEI deploy a documentation policy in support of its research and training activities?
Sample 1
Scientific Research Activities. Indicators:
Sample 1

Related to Scientific Research Activities

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Research Project 3.1 These Materials and Data will be used by Recipient's PI solely in connection with the Research Project, as named and described in the attached research application (insert Research Project name below):

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

Time is Money Join Law Insider Premium to draft better contracts faster.